Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Go back to Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update| (NASDAQ: MIRM) | Delayed: 99.53 -1.37 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.90 | 52 Week High | $ | |||
| Open | $98.49 | 52 Week Low | $ | |||
| Day High | $101.83 | P/E | N/A | |||
| Day Low | $97.65 | EPS | $ | |||
| Volume | 638,466 | |||||

